Venclexta 100 mg/1 (Venetoclax TABLET, FILM COATED) 100 mg/1

Venclexta 100 mg is a medication used to treat certain types of blood cancers. This oral tablet is designed to target specific cells in the body, offering a targeted approach to cancer treatment.

Strength

100 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0074-0576-11) / 1 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Venclexta 100 mg is primarily used in the treatment of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by targeting and destroying cancer cells, helping to manage the progression of these conditions. Patients often wonder, 'What is Venclexta used for?' and the answer lies in its ability to provide a targeted therapy option for these specific types of cancers.

Side Effects

Common effects of Venclexta 100 mg may include fatigue, nausea, and diarrhea. Some patients might experience low blood cell counts, which can lead to increased susceptibility to infections. It's important to monitor these effects and consult a healthcare provider if they become severe or persistent.

Precautions & Warnings

Venclexta 100 mg should be handled with care, as it can cause serious side effects if not used properly. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should also be aware of the potential for tumor lysis syndrome, a condition that can occur when cancer cells break down rapidly.

Avoid Interactions

Venclexta 100 mg may interact with certain medications, including those that are metabolized by the liver enzyme CYP3A. Alcohol and other substances that affect liver function should be avoided or used with caution. It's important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Venclexta is used to treat certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML).

Venclexta is taken orally, typically in the form of a film-coated tablet. The specific dosage and administration schedule should be determined by a healthcare provider.

Common side effects may include fatigue, nausea, diarrhea, and low blood cell counts. Severe or persistent effects should be reported to a healthcare provider.

Venclexta may interact with certain medications, particularly those metabolized by the liver enzyme CYP3A. Always consult a healthcare provider before combining medications.

Precautions include following the prescribed dosage, avoiding alcohol, and being aware of the risk of tumor lysis syndrome. Regular monitoring by a healthcare provider is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.